AVEO Oncology (AVEO) Fails to deliver data

Key failure to deliver metrics for AVEO Oncology :

• Last SEC data release: 2023-12-29
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: N/A
• Last year FTD volume: N/A

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for AVEO Oncology (AVEO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for AVEO Oncology (AVEO) - since 2020

AVEO Oncology (AVEO) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Biogen BIIB	£21.47 M	£75.41 M	🇺🇸 USA
Regeneron Pharmaceuticals REGN	£23.26 M	£51.47 M	🇺🇸 USA
Merrimack Pharmaceuticals MACK	N/A	£4.75 M	🇺🇸 USA
Bristol-Myers Squibb BMY	£30 M	£0.30 B	🇺🇸 USA
Eli Lilly LLY	£47.82 M	£0.19 B	🇺🇸 USA
Amgen AMGN	£0.14 B	£0.33 B	🇺🇸 USA